GPFQ_@'4)@{LAF*D3'_'1X2}4<&<A#[46]|C,4/
SYSTEM PROCESSING...
GPFQ_@'4)@{LAF*D3'_'1X2}4<&<A#[46]|C,4/
SYSTEM PROCESSING...
Posted: 2025-04-10 01:03:31 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-10 01:08:40 UTC
Verified By
Rollup News
A study reveals that pregnant women who received Pfizer's RSV vaccine had a higher likelihood of premature births, confirming concerns from clinical trials that were shared with regulators before the FDA approved the vaccine.
Increased risk of premature births among pregnant women who received Pfizer's RSV vaccine
Confirmation of concerns raised during clinical trials
FDA approval despite existing concerns and shared data
Balancing the benefits of RSV vaccination against the risk of premature births
Addressing concerns raised during clinical trials before vaccine approval
Ensuring transparency and informed consent regarding potential risks